CLINICAL_TRIALS
trial_result
· 2011-05-19
Clinical Trial Update: The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain [Phase 4]
Summary
This Phase 4 study evaluates the effectiveness of Almotriptan Malate (AXERT) 12.5 mg when taken at the onset of migraine pain.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ortho-McNeil Neurologics, Inc. | Conditions: Migraine | Phase 4 | Status: COMPLETED